Advertisement
  • Reuters

    AstraZeneca Imfinzi plus chemotherapy gets US nod for certain type of endometrial cancer

    The approval from the U.S. Food and Drug Administration came after a late stage trial showed that Imfinzi along with chemotherapy drugs carboplatin and paclitaxel, then followed by Imfinzi by itself, reduced the risk of disease progression or death by 58% in specific endometrial cancer patients, compared to chemotherapy alone, the Anglo-Swedish drugmaker said on Monday. "Immunotherapy in combination with chemotherapy is emerging as a new standard of care in this setting, and the approval of Imfinzi offers an important new option for patients with mismatch repair deficient disease," Dave Fredrickson, executive vice-president of the company's oncology business unit, said in a statement.

  • The Independent

    Is Romania vs Ukraine on TV? Channel, start time and how to watch Euro 2024 fixture online today

    Ukraine will be ones to watch at Euro 2024 as Serhiy Rebrov’s side begin their campaign in Munich against Romania

  • NBC Sports Bay Area

    Bivens details how emotional it was to win major league debut

    Spencer Bivens speaks to reporters after the San Francisco Giants' 13-6 win over the Los Angeles Angels on Sunday.Bivens details how emotional it was to win major league debut originally appeared on NBC Sports Bay Area